<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05031169</url>
  </required_header>
  <id_info>
    <org_study_id>PER 331</org_study_id>
    <nct_id>NCT05031169</nct_id>
  </id_info>
  <brief_title>Surgical Management of Interdental Papilla Recession With Advanced Platelet Rich Fibrin or Connective Tissue Graft</brief_title>
  <official_title>Evaluation of Surgical Management of Interdental Papilla Recession With Advanced Platelet Rich Fibrin Compared to Subepthelial Connective Tissue Graft. A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      deficient interdental papillae witt be surgically reconstructed. in one group, connective&#xD;
      tissue graft (SCTG) will be used for papillae augmentation, while in the other group,&#xD;
      advanced platelet rich fibrin (A-PRF). the height of the papillae will be measured&#xD;
      preoperatively as well as post operatively at 3, 6 ,9 and 12 months.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this study is to compare the effect of A-PRF membrane to SCTG when used as&#xD;
      grafting material with the Han and Takei's approach to reconstruct receding interdental&#xD;
      papilla and assess deference in papilla height between the study groups.&#xD;
&#xD;
      The clinical parameters that will be evaluated are:&#xD;
&#xD;
        -  Papilla height (PH)&#xD;
&#xD;
        -  Clinical attachment level (CAL)&#xD;
&#xD;
        -  Probing depth (PD)&#xD;
&#xD;
        -  Post-operative patients' satisfaction about the esthetic outcome&#xD;
&#xD;
        -  Post-operative pain level among patients&#xD;
&#xD;
      Study settings:&#xD;
&#xD;
      This study will be conducted in the postgraduate periodontology clinics in the faculty of&#xD;
      dentistry, Cairo University. The participants will be selected from the outpatient clinic of&#xD;
      the department.&#xD;
&#xD;
      interventionsa:&#xD;
&#xD;
      The first visit:&#xD;
&#xD;
        -  Eligible participants will be interviewed to report medical and dental histories.&#xD;
&#xD;
        -  The participants will receive full mouth dental and periodontal examination.&#xD;
&#xD;
        -  Initial periodontal treatment (supragingival scaling and sub gingival debridement) as&#xD;
           indicated.&#xD;
&#xD;
        -  Patients will be given oral hygiene instruction on proper tooth brushing and flossing.&#xD;
&#xD;
        -  They will be advised to use chlorhexidine mouth wash 0.12% twice daily for 2 weeks.&#xD;
&#xD;
      Second visit:&#xD;
&#xD;
      After 4-6 weeks of initial therapy, patients will be re-examined, and the baseline clinical&#xD;
      parameters will be recorded as follows:&#xD;
&#xD;
        -  Full mouth plaque index and gingival index.&#xD;
&#xD;
        -  Site specific plaque index and gingival index.&#xD;
&#xD;
        -  Type of Papilla deficiency (classification).&#xD;
&#xD;
        -  Papilla height&#xD;
&#xD;
        -  Clinical attachment level&#xD;
&#xD;
        -  Probing depth&#xD;
&#xD;
      The patients then will be randomly allocated to one of the study groups.&#xD;
&#xD;
      Test group:&#xD;
&#xD;
      Deficient papillae in this group will be treated surgically and A-PRF membrane will be used&#xD;
      as a grafting material.&#xD;
&#xD;
      Preparation of A-PRF:&#xD;
&#xD;
      A-PRF preparation protocol will be as described by (Clark et al. 2018):&#xD;
&#xD;
      A blood sample of 10 ml will be obtained from the patient and immediately centrifuged at 1300&#xD;
      rpm for 8 minutes.&#xD;
&#xD;
      Control group:&#xD;
&#xD;
      In this group, papilla recession will be treated surgically and the SCTG will be used as a&#xD;
      grafting material.&#xD;
&#xD;
      sample size calculation was based on a previous study. fourteen experimental subjects and 14&#xD;
      control subjects are required to be able to reject the null hypothesis that the population&#xD;
      means of the experimental and the control groups are equal with probability (power) 0.8. The&#xD;
      type I error probability associated with this test of this null hypothesis is 0.05.&#xD;
&#xD;
      To compensate for anticipated missing data during follow up, this number is increased to 16&#xD;
      per group.&#xD;
&#xD;
      Recruitment&#xD;
&#xD;
        -  Patients will be selected from the outpatient clinic of the Oral Medicine and&#xD;
           Periodontology Department, Faculty of Oral and Dental Medicine-Cairo University&#xD;
&#xD;
        -  Screening of patients will continue until the target sample is achieved.&#xD;
&#xD;
      Allocation&#xD;
&#xD;
      Randomization:&#xD;
&#xD;
      Patients will be randomly assigned to either test or control group using computer generated&#xD;
      randomization (www.randomizer.org) which will be performed by the supervisor. The patients&#xD;
      will be allocated to either test or control group.&#xD;
&#xD;
      Allocation concealment mechanism:&#xD;
&#xD;
      The two groups will be equally prepared for both surgical procedures. Then the decision of&#xD;
      which group will receive papilla treatment with A-PRF (test) and which will receive papilla&#xD;
      treatment with SCTG (control) will be taken according to the randomized numbers placed in&#xD;
      opaque sealed envelopes. The number will be picked by the supervisor.&#xD;
&#xD;
      Implementation:&#xD;
&#xD;
      • All patients who provide an informed consent for participation as well as fulfill the&#xD;
      inclusion criteria will be randomized.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2020</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized clinical trial with 1:1 ratio.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>papilla height</measure>
    <time_frame>base line , 3, 6, 9, and 12 months</time_frame>
    <description>change of papillae height will be recorded using a graduated periodontal probe (UNC 15 probe)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>patient satisfaction</measure>
    <time_frame>3 and 12 months</time_frame>
    <description>patients opinion about esthetic improvement</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">32</enrollment>
  <condition>Recession</condition>
  <arm_group>
    <arm_group_label>A-PRF</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Surgical treatment A-PRF membrane</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SCTG</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Surgical treatment with SCTG</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>interdental papilla surgical reconstructiion</intervention_name>
    <description>Surgical treatment of receding interdentalpapillae</description>
    <arm_group_label>A-PRF</arm_group_label>
    <arm_group_label>SCTG</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Be healthy adults older than 18 years of age and presenting at least one deficient&#xD;
             papilla with papilla presence index 2 or 3&#xD;
&#xD;
          -  Have Interproximal CAL ≤ 3 mm&#xD;
&#xD;
          -  Have probing depth ≤ 3mm&#xD;
&#xD;
          -  Distance between the alveolar bone crest and contact point is less than 7mm.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Smoking.&#xD;
&#xD;
          -  Pregnancy and lactation.&#xD;
&#xD;
          -  Carious and non-carious cervical lesion in the involved teeth around the papilla.&#xD;
&#xD;
          -  Restoration in teeth around the papilla (filling, crown, bridge, facings, clasp of a&#xD;
             partial denture).&#xD;
&#xD;
          -  Open contacts and non-vital teeth&#xD;
&#xD;
          -  Poor oral hygiene with plaque index &gt; 20 %.&#xD;
&#xD;
          -  Tooth mobility&#xD;
&#xD;
          -  History of medication in the previous 3 months&#xD;
&#xD;
          -  History of periodontal surgery in the site to be treated in the past 12 months&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hani ElNahass, Ph D</last_name>
    <role>Study Chair</role>
    <affiliation>Cairo University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Samar ElKohouly, Ph D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cairo University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>sanabel barakat, MSC</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cairo University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>sanabel barakat</last_name>
    <phone>00201550071457</phone>
    <email>snabel.barakat@dentistry.cu.edu.eg</email>
  </overall_contact>
  <location>
    <facility>
      <name>Faculty of Dentistry</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hani ElNahass, PhD</last_name>
      <phone>01000252603</phone>
      <email>nahass77@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Ahila E, Saravana Kumar R, Reddy VK, Pratebha B, Jananni M, Priyadharshini V. Augmentation of Interdental Papilla with Platelet-rich Fibrin. Contemp Clin Dent. 2018 Apr-Jun;9(2):213-217. doi: 10.4103/ccd.ccd_812_17.</citation>
    <PMID>29875563</PMID>
  </reference>
  <reference>
    <citation>Cardaropoli D, Re S, Corrente G, Abundo R. Reconstruction of the maxillary midline papilla following a combined orthodontic-periodontic treatment in adult periodontal patients. J Clin Periodontol. 2004 Feb;31(2):79-84.</citation>
    <PMID>15016030</PMID>
  </reference>
  <reference>
    <citation>Augusta, Maria and Matas Hennig. 2016. &quot;Absence of Interdental Papilla - Systematic Review of Available Therapeutic Modalities.&quot; Stomatos 22(43):31-43.</citation>
  </reference>
  <reference>
    <citation>Chaulkar PP, Mali RS, Mali AM, Lele PA, Patil PA. A comparative evaluation of papillary reconstruction by modified Beagle's technique with the Beagle's surgical technique: A clinical and radiographic study. J Indian Soc Periodontol. 2017 May-Jun;21(3):218-223. doi: 10.4103/jisp.jisp_166_17.</citation>
    <PMID>29440789</PMID>
  </reference>
  <reference>
    <citation>Clark D, Rajendran Y, Paydar S, Ho S, Cox D, Ryder M, Dollard J, Kao RT. Advanced platelet-rich fibrin and freeze-dried bone allograft for ridge preservation: A randomized controlled clinical trial. J Periodontol. 2018 Apr;89(4):379-387. doi: 10.1002/JPER.17-0466.</citation>
    <PMID>29683498</PMID>
  </reference>
  <reference>
    <citation>Eren G, Atilla G. Platelet-rich fibrin in the treatment of localized gingival recessions: a split-mouth randomized clinical trial. Clin Oral Investig. 2014 Nov;18(8):1941-8. doi: 10.1007/s00784-013-1170-5. Epub 2013 Dec 22.</citation>
    <PMID>24362634</PMID>
  </reference>
  <reference>
    <citation>Ghanaati S, Booms P, Orlowska A, Kubesch A, Lorenz J, Rutkowski J, Landes C, Sader R, Kirkpatrick C, Choukroun J. Advanced platelet-rich fibrin: a new concept for cell-based tissue engineering by means of inflammatory cells. J Oral Implantol. 2014 Dec;40(6):679-89. doi: 10.1563/aaid-joi-D-14-00138.</citation>
    <PMID>24945603</PMID>
  </reference>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 29, 2021</study_first_submitted>
  <study_first_submitted_qc>August 31, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 1, 2021</study_first_posted>
  <last_update_submitted>August 31, 2021</last_update_submitted>
  <last_update_submitted_qc>August 31, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Sanabel Osama Omran Barakat</investigator_full_name>
    <investigator_title>Ph d candidate</investigator_title>
  </responsible_party>
  <keyword>interdental papilla reconstriction</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

